Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more
Market Cap & Net Worth: Millennium Pharmacon International (SDPC)
Millennium Pharmacon International (JK:SDPC) has a market capitalization of $15.11 Million (Rp245.88 Billion) as of March 18, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #34639 globally and #782 in its home market, demonstrating a -1.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Millennium Pharmacon International's stock price Rp193.00 by its total outstanding shares 1274000000 (1.27 Billion).
Millennium Pharmacon International Market Cap History: 2015 to 2026
Millennium Pharmacon International's market capitalization history from 2015 to 2026. Data shows growth from $4.57 Million to $15.11 Million (12.34% CAGR).
Index Memberships
Millennium Pharmacon International is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$148.31 Billion | 0.00% | #715 of 864 |
Weight: Millennium Pharmacon International's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Millennium Pharmacon International Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Millennium Pharmacon International's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Millennium Pharmacon International's market cap is 0.00 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Millennium Pharmacon International's market cap is 0.00 times its annual earnings
9.21x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.57 Million | $1.71 Trillion | $11.91 Billion | 0.00x | 0.00x |
| 2016 | $6.45 Million | $1.97 Trillion | $11.11 Billion | 0.00x | 0.00x |
| 2017 | $7.80 Million | $2.11 Trillion | $14.18 Billion | 0.00x | 0.00x |
| 2018 | $6.87 Million | $2.38 Trillion | $19.44 Billion | 0.00x | 0.00x |
| 2019 | $7.06 Million | $2.73 Trillion | $7.88 Billion | 0.00x | 0.00x |
| 2020 | $7.78 Million | $2.64 Trillion | $2.80 Billion | 0.00x | 0.00x |
| 2021 | $10.22 Million | $2.99 Trillion | $9.57 Billion | 0.00x | 0.00x |
| 2022 | $25.13 Million | $3.20 Trillion | $24.46 Billion | 0.00x | 0.00x |
| 2023 | $12.14 Million | $3.36 Trillion | $33.09 Billion | 0.00x | 0.00x |
| 2024 | $10.34 Million | $3.92 Trillion | $16.91 Billion | 0.00x | 0.00x |
Competitor Companies of SDPC by Market Capitalization
Companies near Millennium Pharmacon International in the global market cap rankings as of March 18, 2026.
Key companies related to Millennium Pharmacon International by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Millennium Pharmacon International Historical Marketcap From 2015 to 2026
Between 2015 and today, Millennium Pharmacon International's market cap moved from $4.57 Million to $ 15.11 Million, with a yearly change of 12.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp15.11 Million | +24.52% |
| 2025 | Rp12.14 Million | +17.42% |
| 2024 | Rp10.34 Million | -14.84% |
| 2023 | Rp12.14 Million | -51.70% |
| 2022 | Rp25.13 Million | +145.98% |
| 2021 | Rp10.22 Million | +31.27% |
| 2020 | Rp7.78 Million | +10.23% |
| 2019 | Rp7.06 Million | +2.78% |
| 2018 | Rp6.87 Million | -11.94% |
| 2017 | Rp7.80 Million | +20.91% |
| 2016 | Rp6.45 Million | +41.10% |
| 2015 | Rp4.57 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Millennium Pharmacon International was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.11 Million USD |
| MoneyControl | $15.11 Million USD |
| MarketWatch | $15.11 Million USD |
| marketcap.company | $15.11 Million USD |
| Reuters | $15.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.